5Bachot N, Revuz J, Roujeau JC. Intravenous immunoglobulin treatment for Stevens- Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no TENefit on mortality or progression. Arch Dermol 2003 ; 139 ( 1 ) : 33 - 36.
5Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin[J]. Br J Dermatol, 1956, 68(11): 355-361.
6Melish ME, Glasgow LA. The staphylococcal scalded-skin syndrome.[J]. N Engl J Med, 1970, 282(20): 1114-1119.
7Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme[J]. Arch Dermatol, 1993, 129(1): 92-96.
8Kelly JP, Auquier A, Rzany B, et al. An international collaborative case-control study of severe cutaneous adverse reactions (SCAR).Design and methods[J]. J Clin Epidemiol, 1995, 48(9): 1099-1108.
9Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis[J]. N Engl J Med, 1995, 333(24): 1600-1607.
10Dietrich A, Kawakubo Y, Rzany B, et al. Low N-acetylating capacity in patients with Stevens-Johnson syndrome and toxic epidermal neerolysis[J]. Exp Dermatol,1995, 4(5): 313-316.
